prof. MUDr. Luděk Pour, Ph.D.
Professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2830, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 500
2021
-
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data
European Journal of Haematology, year: 2021, volume: 107, edition: 4, DOI
-
Castlemanova nemoc – neinfekční a nemaligní lymfadenopatie se zvýšenou koncentrací polyklonálních imunoglobulinů a systémovými zánětlivými projevy.
Acta medicinae, year: 2021, edition: 4
-
Efficacy and safety of weekly carfilzomib (70 mg/m(2)), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option: a cross-study comparison of the CANDOR and EQUULEUS studies
LEUKEMIA & LYMPHOMA, year: 2021, volume: 62, edition: 2, DOI
-
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
haematologica, year: 2021, volume: 106, edition: 2, DOI
-
Léčba multicentrické a unicentrické formy Castlemanovy choroby
Farmakoterapie, year: 2021, volume: 17(3)
-
Léčba tří pacientů s Erdheimovou-Chesterovou chorobou kladribinem, případně kombinací kladribinu a cyklofosfamidu a přehled léčby této nemoci
Vnitřní lékařství, year: 2021, volume: 67, edition: 3, DOI
-
LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients
Biomedicines, year: 2021, volume: 9, edition: 11, DOI
-
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia
British journal of haematology, year: 2021, volume: 195, edition: 1, DOI
-
Nemaligní a neinfekční příčina lymfadenopatie – Castlemanova choroba. Klinické projevy a stanovení diagnózy
Farmakoterapie, year: 2021, volume: 17, edition: 3
-
Onemocnění asociované s imunoglobulinem IgG4 – klinické projevy a léčba
Farmakoterapie, year: 2021, volume: 17, edition: 3